GLMD
Price
$1.36
Change
+$0.08 (+6.25%)
Updated
Sep 5 closing price
Capitalization
7.01M
65 days until earnings call
TLPPF
Price
$9.04
Change
-$0.18 (-1.95%)
Updated
Sep 5 closing price
Capitalization
3.02B
Interact to see
Advertisement

GLMD vs TLPPF

Header iconGLMD vs TLPPF Comparison
Open Charts GLMD vs TLPPFBanner chart's image
Galmed Pharmaceuticals
Price$1.36
Change+$0.08 (+6.25%)
Volume$62.08K
Capitalization7.01M
Telix Pharmaceutical
Price$9.04
Change-$0.18 (-1.95%)
Volume$569
Capitalization3.02B
GLMD vs TLPPF Comparison Chart in %
Loading...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLMD vs. TLPPF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a StrongBuy and TLPPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GLMD: $1.36 vs. TLPPF: $9.04)
Brand notoriety: GLMD and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 22% vs. TLPPF: 7%
Market capitalization -- GLMD: $7.01M vs. TLPPF: $3.02B
GLMD [@Biotechnology] is valued at $7.01M. TLPPF’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 1 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • GLMD’s FA Score: 1 green, 4 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than GLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • GLMD’s TA Score: 5 bullish, 3 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than TLPPF.

Price Growth

GLMD (@Biotechnology) experienced а +7.09% price change this week, while TLPPF (@Biotechnology) price change was -8.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

GLMD is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($3.02B) has a higher market cap than GLMD($7.01M). TLPPF has higher P/E ratio than GLMD: TLPPF (387.72) vs GLMD (0.02). TLPPF YTD gains are higher at: -39.633 vs. GLMD (-57.367). TLPPF has higher annual earnings (EBITDA): 92.5M vs. GLMD (-6.07M). TLPPF has more cash in the bank: 710M vs. GLMD (15.7M). GLMD has less debt than TLPPF: GLMD (41K) vs TLPPF (581M). TLPPF has higher revenues than GLMD: TLPPF (783M) vs GLMD (0).
GLMDTLPPFGLMD / TLPPF
Capitalization7.01M3.02B0%
EBITDA-6.07M92.5M-7%
Gain YTD-57.367-39.633145%
P/E Ratio0.02387.720%
Revenue0783M-
Total Cash15.7M710M2%
Total Debt41K581M0%
FUNDAMENTALS RATINGS
GLMD vs TLPPF: Fundamental Ratings
GLMD
TLPPF
OUTLOOK RATING
1..100
5258
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
10056
SMR RATING
1..100
9768
PRICE GROWTH RATING
1..100
9094
P/E GROWTH RATING
1..100
965
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for TLPPF (93) in the null industry. This means that GLMD’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for GLMD (100) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew somewhat faster than GLMD’s over the last 12 months.

TLPPF's SMR Rating (68) in the null industry is in the same range as GLMD (97) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew similarly to GLMD’s over the last 12 months.

GLMD's Price Growth Rating (90) in the Pharmaceuticals Other industry is in the same range as TLPPF (94) in the null industry. This means that GLMD’s stock grew similarly to TLPPF’s over the last 12 months.

TLPPF's P/E Growth Rating (5) in the null industry is significantly better than the same rating for GLMD (96) in the Pharmaceuticals Other industry. This means that TLPPF’s stock grew significantly faster than GLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDTLPPF
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIVS2.510.25
+11.06%
VivoSim Lab Inc
DOCU79.863.62
+4.75%
DocuSign
CEVA22.730.36
+1.61%
CEVA
ASH54.910.67
+1.24%
Ashland
CNTB1.75-0.03
-1.69%
Connect Biopharma Holdings Limited

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+6.25%
XBIO - GLMD
88%
Closely correlated
-0.17%
JSPR - GLMD
31%
Poorly correlated
+1.12%
CDTX - GLMD
28%
Poorly correlated
-2.71%
CRVS - GLMD
28%
Poorly correlated
+7.50%
VTVT - GLMD
28%
Poorly correlated
-1.24%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
-1.95%
GLMD - TLPPF
25%
Poorly correlated
+6.25%
DNLI - TLPPF
24%
Poorly correlated
+4.33%
BEAM - TLPPF
24%
Poorly correlated
+12.62%
RXRX - TLPPF
23%
Poorly correlated
+1.99%
JANX - TLPPF
23%
Poorly correlated
+0.17%
More